

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glycosphingolipid catabolic process (GO:0046479) | 6.18098118 |
| 2 | oligosaccharide catabolic process (GO:0009313) | 5.92402017 |
| 3 | glycolipid catabolic process (GO:0019377) | 5.57444082 |
| 4 | amino sugar catabolic process (GO:0046348) | 5.35449113 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 5.19750135 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.19750135 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.18248066 |
| 8 | cellular response to thyroid hormone stimulus (GO:0097067) | 5.05756716 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.02558759 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 5.02558759 |
| 11 | ceramide catabolic process (GO:0046514) | 4.98189916 |
| 12 | aromatic amino acid family catabolic process (GO:0009074) | 4.84188588 |
| 13 | complement activation, alternative pathway (GO:0006957) | 4.74326083 |
| 14 | regulation of mononuclear cell migration (GO:0071675) | 4.69104803 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 4.65051153 |
| 16 | indole-containing compound catabolic process (GO:0042436) | 4.50243547 |
| 17 | indolalkylamine catabolic process (GO:0046218) | 4.50243547 |
| 18 | tryptophan catabolic process (GO:0006569) | 4.50243547 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 4.48406094 |
| 20 | response to peptidoglycan (GO:0032494) | 4.48348778 |
| 21 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.42458909 |
| 22 | urea cycle (GO:0000050) | 4.40704559 |
| 23 | urea metabolic process (GO:0019627) | 4.40704559 |
| 24 | plasma lipoprotein particle clearance (GO:0034381) | 4.37894285 |
| 25 | regulation of triglyceride catabolic process (GO:0010896) | 4.36381828 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 4.35663445 |
| 27 | kynurenine metabolic process (GO:0070189) | 4.31865143 |
| 28 | cysteine metabolic process (GO:0006534) | 4.29693100 |
| 29 | tryptophan metabolic process (GO:0006568) | 4.25332142 |
| 30 | bile acid biosynthetic process (GO:0006699) | 4.20980033 |
| 31 | protein carboxylation (GO:0018214) | 4.16005310 |
| 32 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.16005310 |
| 33 | N-acetylneuraminate metabolic process (GO:0006054) | 4.15621808 |
| 34 | regulation of protein activation cascade (GO:2000257) | 4.13792945 |
| 35 | low-density lipoprotein particle clearance (GO:0034383) | 4.09482616 |
| 36 | glyoxylate metabolic process (GO:0046487) | 4.05175314 |
| 37 | nitrogen cycle metabolic process (GO:0071941) | 4.03341310 |
| 38 | response to thyroid hormone (GO:0097066) | 4.01455357 |
| 39 | high-density lipoprotein particle remodeling (GO:0034375) | 4.01347594 |
| 40 | membrane lipid catabolic process (GO:0046466) | 4.01086917 |
| 41 | negative regulation of fibrinolysis (GO:0051918) | 3.99522401 |
| 42 | regulation of complement activation (GO:0030449) | 3.94727054 |
| 43 | regulation of fibrinolysis (GO:0051917) | 3.93570846 |
| 44 | sphingolipid catabolic process (GO:0030149) | 3.92585117 |
| 45 | immunoglobulin mediated immune response (GO:0016064) | 3.90320369 |
| 46 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.88891503 |
| 47 | phospholipid efflux (GO:0033700) | 3.88698976 |
| 48 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.87360528 |
| 49 | acylglycerol homeostasis (GO:0055090) | 3.80994950 |
| 50 | triglyceride homeostasis (GO:0070328) | 3.80994950 |
| 51 | homocysteine metabolic process (GO:0050667) | 3.77730313 |
| 52 | T-helper 1 type immune response (GO:0042088) | 3.76669068 |
| 53 | macrophage activation involved in immune response (GO:0002281) | 3.74729978 |
| 54 | * negative regulation of interleukin-12 production (GO:0032695) | 3.74711658 |
| 55 | lysine metabolic process (GO:0006553) | 3.73309917 |
| 56 | lysine catabolic process (GO:0006554) | 3.73309917 |
| 57 | positive regulation of lipid catabolic process (GO:0050996) | 3.71832569 |
| 58 | serine family amino acid catabolic process (GO:0009071) | 3.71315523 |
| 59 | regulation of cholesterol esterification (GO:0010872) | 3.71051117 |
| 60 | bile acid metabolic process (GO:0008206) | 3.69042584 |
| 61 | plasma lipoprotein particle remodeling (GO:0034369) | 3.68389555 |
| 62 | protein-lipid complex remodeling (GO:0034368) | 3.68389555 |
| 63 | macromolecular complex remodeling (GO:0034367) | 3.68389555 |
| 64 | reverse cholesterol transport (GO:0043691) | 3.67911976 |
| 65 | myeloid dendritic cell differentiation (GO:0043011) | 3.67216385 |
| 66 | amino-acid betaine metabolic process (GO:0006577) | 3.65353005 |
| 67 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.64938423 |
| 68 | barbed-end actin filament capping (GO:0051016) | 3.64738955 |
| 69 | valine metabolic process (GO:0006573) | 3.63746598 |
| 70 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.58909409 |
| 71 | positive regulation of leukocyte degranulation (GO:0043302) | 3.55708461 |
| 72 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.49698694 |
| 73 | plasma lipoprotein particle assembly (GO:0034377) | 3.49255818 |
| 74 | aromatic amino acid family metabolic process (GO:0009072) | 3.47933681 |
| 75 | negative regulation of sterol transport (GO:0032372) | 3.47544684 |
| 76 | negative regulation of cholesterol transport (GO:0032375) | 3.47544684 |
| 77 | positive regulation of antigen processing and presentation (GO:0002579) | 3.46934254 |
| 78 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.45400687 |
| 79 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.45400687 |
| 80 | regulation of macrophage chemotaxis (GO:0010758) | 3.44438569 |
| 81 | regulation of cholesterol storage (GO:0010885) | 3.40719420 |
| 82 | regulation of mast cell degranulation (GO:0043304) | 3.39312814 |
| 83 | positive regulation of mast cell activation (GO:0033005) | 3.37415221 |
| 84 | positive regulation of cholesterol efflux (GO:0010875) | 3.36724013 |
| 85 | positive regulation of mast cell degranulation (GO:0043306) | 3.36548458 |
| 86 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.36548458 |
| 87 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.36517638 |
| 88 | cholesterol efflux (GO:0033344) | 3.35126783 |
| 89 | tyrosine metabolic process (GO:0006570) | 3.34784923 |
| 90 | aldehyde catabolic process (GO:0046185) | 3.34753029 |
| 91 | ethanol oxidation (GO:0006069) | 3.34094999 |
| 92 | myeloid dendritic cell activation (GO:0001773) | 3.33204092 |
| 93 | complement activation (GO:0006956) | 3.29573286 |
| 94 | fatty acid beta-oxidation (GO:0006635) | 3.29544927 |
| 95 | acetyl-CoA metabolic process (GO:0006084) | 3.27779652 |
| 96 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.26320013 |
| 97 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.25811889 |
| 98 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.24864456 |
| 99 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.24864456 |
| 100 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.22991935 |
| 101 | alpha-amino acid catabolic process (GO:1901606) | 3.22923448 |
| 102 | phospholipid homeostasis (GO:0055091) | 3.22866165 |
| 103 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.22346738 |
| 104 | NIK/NF-kappaB signaling (GO:0038061) | 3.21293812 |
| 105 | detection of molecule of bacterial origin (GO:0032490) | 3.20094264 |
| 106 | fatty acid oxidation (GO:0019395) | 3.19998857 |
| 107 | protein-lipid complex assembly (GO:0065005) | 3.19202124 |
| 108 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.18355162 |
| 109 | regulation of monocyte chemotaxis (GO:0090025) | 3.16552486 |
| 110 | monocyte chemotaxis (GO:0002548) | 3.16285180 |
| 111 | complement activation, classical pathway (GO:0006958) | 3.16009900 |
| 112 | lipid oxidation (GO:0034440) | 3.16001893 |
| 113 | phagosome maturation (GO:0090382) | 3.14568709 |
| 114 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.13151748 |
| 115 | acute-phase response (GO:0006953) | 3.13026233 |
| 116 | regulation of leukocyte degranulation (GO:0043300) | 3.12811340 |
| 117 | regulation of antigen processing and presentation (GO:0002577) | 3.12235103 |
| 118 | cholesterol homeostasis (GO:0042632) | 3.11105412 |
| 119 | plasma lipoprotein particle organization (GO:0071827) | 3.11079159 |
| 120 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.11076965 |
| 121 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.10312321 |
| 122 | bile acid and bile salt transport (GO:0015721) | 3.10241561 |
| 123 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.09860607 |
| 124 | fibrinolysis (GO:0042730) | 3.08889455 |
| 125 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.08625952 |
| 126 | regulation of cholesterol homeostasis (GO:2000188) | 3.08255957 |
| 127 | indolalkylamine metabolic process (GO:0006586) | 3.07924003 |
| 128 | detection of other organism (GO:0098543) | 3.07813747 |
| 129 | granulocyte activation (GO:0036230) | 3.07212738 |
| 130 | sterol homeostasis (GO:0055092) | 3.06590908 |
| 131 | protein activation cascade (GO:0072376) | 3.06194918 |
| 132 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.05857137 |
| 133 | cytolysis (GO:0019835) | 3.05651097 |
| 134 | keratan sulfate catabolic process (GO:0042340) | 3.05059989 |
| 135 | glycine metabolic process (GO:0006544) | 3.04736024 |
| 136 | cellular biogenic amine catabolic process (GO:0042402) | 3.03451703 |
| 137 | amine catabolic process (GO:0009310) | 3.03451703 |
| 138 | fatty acid catabolic process (GO:0009062) | 3.03419128 |
| 139 | positive regulation by symbiont of host defense response (GO:0052509) | 3.01825795 |
| 140 | modulation by symbiont of host defense response (GO:0052031) | 3.01825795 |
| 141 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.01825795 |
| 142 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.01825795 |
| 143 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.01825795 |
| 144 | modulation by symbiont of host immune response (GO:0052553) | 3.01825795 |
| 145 | cofactor catabolic process (GO:0051187) | 3.00985426 |
| 146 | cellular glucuronidation (GO:0052695) | 3.00925369 |
| 147 | cellular amino acid catabolic process (GO:0009063) | 3.00544588 |
| 148 | dendritic cell differentiation (GO:0097028) | 2.99710350 |
| 149 | serine family amino acid metabolic process (GO:0009069) | 2.99193341 |
| 150 | cellular ketone body metabolic process (GO:0046950) | 2.97307146 |
| 151 | low-density lipoprotein particle remodeling (GO:0034374) | 2.97149399 |
| 152 | benzene-containing compound metabolic process (GO:0042537) | 2.96821824 |
| 153 | 2-oxoglutarate metabolic process (GO:0006103) | 2.96737670 |
| 154 | protein-lipid complex subunit organization (GO:0071825) | 2.96091637 |
| 155 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.95752414 |
| 156 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.95752414 |
| 157 | regulation of sequestering of triglyceride (GO:0010889) | 2.95660810 |
| 158 | regulation of podosome assembly (GO:0071801) | 2.95422570 |
| 159 | monocarboxylic acid catabolic process (GO:0072329) | 2.94186902 |
| 160 | apoptotic cell clearance (GO:0043277) | 2.94015817 |
| 161 | detection of external biotic stimulus (GO:0098581) | 2.93704743 |
| 162 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.90399891 |
| 163 | ganglioside metabolic process (GO:0001573) | 2.90312183 |
| 164 | peptide catabolic process (GO:0043171) | 2.88351805 |
| 165 | negative regulation of cell killing (GO:0031342) | 2.86047861 |
| 166 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.86047861 |
| 167 | regulation of mast cell activation (GO:0033003) | 2.85810628 |
| 168 | lytic vacuole organization (GO:0080171) | 2.84278211 |
| 169 | lysosome organization (GO:0007040) | 2.84278211 |
| 170 | cellular extravasation (GO:0045123) | 2.83640382 |
| 171 | macrophage differentiation (GO:0030225) | 2.83591265 |
| 172 | virion attachment to host cell (GO:0019062) | 2.83347744 |
| 173 | adhesion of symbiont to host cell (GO:0044650) | 2.83347744 |
| 174 | respiratory burst (GO:0045730) | 2.83290199 |
| 175 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.82047085 |
| 176 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.81988372 |
| 177 | pinocytosis (GO:0006907) | 2.81919784 |
| 178 | eosinophil chemotaxis (GO:0048245) | 2.81690040 |
| 179 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.81463227 |
| 180 | cellular response to arsenic-containing substance (GO:0071243) | 2.81005693 |
| 181 | positive regulation of sterol transport (GO:0032373) | 2.80986736 |
| 182 | positive regulation of cholesterol transport (GO:0032376) | 2.80986736 |
| 183 | vitamin D metabolic process (GO:0042359) | 2.80883638 |
| 184 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.79679839 |
| 185 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.79518559 |
| 186 | B cell mediated immunity (GO:0019724) | 2.77837035 |
| 187 | detection of bacterium (GO:0016045) | 2.75377374 |
| 188 | germinal center formation (GO:0002467) | 2.75204755 |
| 189 | protein localization to endosome (GO:0036010) | 2.74755567 |
| 190 | myeloid cell activation involved in immune response (GO:0002275) | 2.72657171 |
| 191 | macrophage activation (GO:0042116) | 2.72095674 |
| 192 | mannose metabolic process (GO:0006013) | 2.71942507 |
| 193 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.71865744 |
| 194 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.69847349 |
| 195 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.69147799 |
| 196 | negative regulation of lipid storage (GO:0010888) | 2.67514632 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.99052048 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.74436331 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.72721300 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.18948947 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.60201778 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.43997000 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.21647955 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.62568801 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.54477517 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.88780509 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.76860044 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.74010368 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.55746991 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.49388345 |
| 15 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.31061189 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.21817814 |
| 17 | SPI1_23127762_ChIP-Seq_K562_Human | 2.18696812 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.11830389 |
| 19 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.03870298 |
| 20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.95998707 |
| 21 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.92718406 |
| 22 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.92655132 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.88634368 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.87861069 |
| 25 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.86941245 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.86308055 |
| 27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.85672925 |
| 28 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.79181595 |
| 29 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.78177404 |
| 30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.75523401 |
| 31 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.73791172 |
| 32 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66777375 |
| 33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.63889811 |
| 34 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58708377 |
| 35 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.56887941 |
| 36 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.55998492 |
| 37 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.54949389 |
| 38 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.54905685 |
| 39 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.51254406 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.50947806 |
| 41 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.45600386 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.43407383 |
| 43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.41883673 |
| 44 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36431793 |
| 45 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.36024937 |
| 46 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.32072365 |
| 47 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.31680478 |
| 48 | * MAF_26560356_Chip-Seq_TH1_Human | 1.27349850 |
| 49 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.25817049 |
| 50 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.23578646 |
| 51 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20704604 |
| 52 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.20639608 |
| 53 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.20283488 |
| 54 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15873733 |
| 55 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.15864834 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.15475669 |
| 57 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.13686106 |
| 58 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.11956676 |
| 59 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.11585836 |
| 60 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.08677133 |
| 61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08228197 |
| 62 | MYB_26560356_Chip-Seq_TH2_Human | 1.07970330 |
| 63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07818395 |
| 64 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.07584922 |
| 65 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07027765 |
| 66 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05625043 |
| 67 | * MYB_26560356_Chip-Seq_TH1_Human | 1.05350623 |
| 68 | GATA1_19941826_ChIP-Seq_K562_Human | 1.04553492 |
| 69 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.03379225 |
| 70 | UTX_26944678_Chip-Seq_JUKART_Human | 1.03353181 |
| 71 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.03110470 |
| 72 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02670080 |
| 73 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.00629448 |
| 74 | MYC_22102868_ChIP-Seq_BL_Human | 0.99677926 |
| 75 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.99370691 |
| 76 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.97436247 |
| 77 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96561879 |
| 78 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95820498 |
| 79 | MAF_26560356_Chip-Seq_TH2_Human | 0.95763339 |
| 80 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.95088335 |
| 81 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94628033 |
| 82 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.93025398 |
| 83 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92907268 |
| 84 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92770820 |
| 85 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92352858 |
| 86 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90686193 |
| 87 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.90315969 |
| 88 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90259378 |
| 89 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.89655410 |
| 90 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.89102325 |
| 91 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.88847427 |
| 92 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.88769181 |
| 93 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88687097 |
| 94 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87863760 |
| 95 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.87813870 |
| 96 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.87620258 |
| 97 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87097238 |
| 98 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.86699318 |
| 99 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.85954541 |
| 100 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85436736 |
| 101 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84743643 |
| 102 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.84139284 |
| 103 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.84095362 |
| 104 | KDM2B_26808549_Chip-Seq_K562_Human | 0.83692346 |
| 105 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.83585303 |
| 106 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.83298913 |
| 107 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81948067 |
| 108 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.81429442 |
| 109 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81233954 |
| 110 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80674863 |
| 111 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80302811 |
| 112 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.80276235 |
| 113 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.78259231 |
| 114 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78095064 |
| 115 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.77179026 |
| 116 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.75091249 |
| 117 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.74943857 |
| 118 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.74244867 |
| 119 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73541263 |
| 120 | P300_27268052_Chip-Seq_Bcells_Human | 0.73222650 |
| 121 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.71399632 |
| 122 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.69867588 |
| 123 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.69730406 |
| 124 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.69038891 |
| 125 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.68437662 |
| 126 | GATA3_26560356_Chip-Seq_TH2_Human | 0.68061546 |
| 127 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.67674841 |
| 128 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.67394011 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.53871259 |
| 2 | MP0005360_urolithiasis | 5.45248153 |
| 3 | MP0005365_abnormal_bile_salt | 4.19710095 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.05124967 |
| 5 | MP0003172_abnormal_lysosome_physiology | 3.35357191 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.26173403 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.02251098 |
| 8 | MP0009840_abnormal_foam_cell | 2.91018876 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.89257539 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.61858537 |
| 11 | MP0003252_abnormal_bile_duct | 2.54271710 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.15058791 |
| 13 | MP0004510_myositis | 2.12445971 |
| 14 | MP0000609_abnormal_liver_physiology | 2.10371608 |
| 15 | MP0005083_abnormal_biliary_tract | 2.05748718 |
| 16 | MP0003436_decreased_susceptibility_to | 2.05717773 |
| 17 | MP0003195_calcinosis | 2.03594713 |
| 18 | MP0005332_abnormal_amino_acid | 2.03440133 |
| 19 | MP0005670_abnormal_white_adipose | 1.96236940 |
| 20 | MP0003656_abnormal_erythrocyte_physiolo | 1.93894236 |
| 21 | MP0001666_abnormal_nutrient_absorption | 1.93339525 |
| 22 | MP0003724_increased_susceptibility_to | 1.89792784 |
| 23 | MP0009785_altered_susceptibility_to | 1.83986156 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 1.78993699 |
| 25 | MP0003329_amyloid_beta_deposits | 1.77531779 |
| 26 | * MP0002998_abnormal_bone_remodeling | 1.76193202 |
| 27 | MP0003186_abnormal_redox_activity | 1.72297521 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.69926800 |
| 29 | MP0005310_abnormal_salivary_gland | 1.69136580 |
| 30 | MP0009278_abnormal_bone_marrow | 1.64225637 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.63374985 |
| 32 | MP0004019_abnormal_vitamin_homeostasis | 1.62240817 |
| 33 | MP0000685_abnormal_immune_system | 1.59809681 |
| 34 | MP0006082_CNS_inflammation | 1.57206994 |
| 35 | MP0005025_abnormal_response_to | 1.55815444 |
| 36 | MP0009764_decreased_sensitivity_to | 1.55477500 |
| 37 | MP0005167_abnormal_blood-brain_barrier | 1.51073153 |
| 38 | * MP0002419_abnormal_innate_immunity | 1.48305515 |
| 39 | MP0001800_abnormal_humoral_immune | 1.48116589 |
| 40 | MP0005387_immune_system_phenotype | 1.47968067 |
| 41 | MP0001790_abnormal_immune_system | 1.47968067 |
| 42 | MP0008469_abnormal_protein_level | 1.46860955 |
| 43 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.46312259 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 1.45094672 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.44064943 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.44064943 |
| 47 | MP0005000_abnormal_immune_tolerance | 1.41268436 |
| 48 | MP0005464_abnormal_platelet_physiology | 1.40606841 |
| 49 | MP0005671_abnormal_response_to | 1.39697776 |
| 50 | MP0009643_abnormal_urine_homeostasis | 1.39274699 |
| 51 | MP0004130_abnormal_muscle_cell | 1.38419484 |
| 52 | MP0005666_abnormal_adipose_tissue | 1.37933966 |
| 53 | MP0001764_abnormal_homeostasis | 1.37914288 |
| 54 | MP0003453_abnormal_keratinocyte_physiol | 1.36279961 |
| 55 | MP0005058_abnormal_lysosome_morphology | 1.35099737 |
| 56 | MP0004185_abnormal_adipocyte_glucose | 1.29130872 |
| 57 | MP0005451_abnormal_body_composition | 1.28452765 |
| 58 | MP0000604_amyloidosis | 1.27307511 |
| 59 | * MP0002452_abnormal_antigen_presenting | 1.26323488 |
| 60 | MP0002723_abnormal_immune_serum | 1.24751057 |
| 61 | MP0001845_abnormal_inflammatory_respons | 1.24468831 |
| 62 | MP0005257_abnormal_intraocular_pressure | 1.24219925 |
| 63 | MP0009763_increased_sensitivity_to | 1.23564525 |
| 64 | MP0002148_abnormal_hypersensitivity_rea | 1.23139505 |
| 65 | MP0000920_abnormal_myelination | 1.22649123 |
| 66 | MP0003303_peritoneal_inflammation | 1.21434746 |
| 67 | MP0006054_spinal_hemorrhage | 1.20044461 |
| 68 | MP0008260_abnormal_autophagy | 1.19209405 |
| 69 | MP0001853_heart_inflammation | 1.17375741 |
| 70 | MP0004947_skin_inflammation | 1.16067363 |
| 71 | MP0002254_reproductive_system_inflammat | 1.15996484 |
| 72 | MP0003828_pulmonary_edema | 1.14573482 |
| 73 | MP0000598_abnormal_liver_morphology | 1.13510420 |
| 74 | MP0001533_abnormal_skeleton_physiology | 1.11672759 |
| 75 | MP0002877_abnormal_melanocyte_morpholog | 1.09485758 |
| 76 | * MP0001819_abnormal_immune_cell | 1.08521263 |
| 77 | * MP0002420_abnormal_adaptive_immunity | 1.08432031 |
| 78 | MP0002971_abnormal_brown_adipose | 1.07923052 |
| 79 | MP0002090_abnormal_vision | 1.06579207 |
| 80 | MP0008438_abnormal_cutaneous_collagen | 1.05643005 |
| 81 | MP0002166_altered_tumor_susceptibility | 1.04121266 |
| 82 | MP0010155_abnormal_intestine_physiology | 1.03824626 |
| 83 | MP0008004_abnormal_stomach_pH | 1.02992828 |
| 84 | MP0003183_abnormal_peptide_metabolism | 0.98115166 |
| 85 | MP0005334_abnormal_fat_pad | 0.98015447 |
| 86 | MP0009115_abnormal_fat_cell | 0.96030601 |
| 87 | MP0002405_respiratory_system_inflammati | 0.95619342 |
| 88 | MP0005636_abnormal_mineral_homeostasis | 0.94886097 |
| 89 | MP0004883_abnormal_blood_vessel | 0.93463832 |
| 90 | MP0005165_increased_susceptibility_to | 0.93097415 |
| 91 | MP0005164_abnormal_response_to | 0.92848529 |
| 92 | MP0002136_abnormal_kidney_physiology | 0.92844762 |
| 93 | MP0002006_tumorigenesis | 0.92749905 |
| 94 | MP0003011_delayed_dark_adaptation | 0.92360701 |
| 95 | MP0003763_abnormal_thymus_physiology | 0.91650338 |
| 96 | MP0002876_abnormal_thyroid_physiology | 0.90199035 |
| 97 | MP0003300_gastrointestinal_ulcer | 0.89133685 |
| 98 | MP0004147_increased_porphyrin_level | 0.88874698 |
| 99 | MP0009333_abnormal_splenocyte_physiolog | 0.87900549 |
| 100 | MP0000371_diluted_coat_color | 0.87773175 |
| 101 | MP0003634_abnormal_glial_cell | 0.87367744 |
| 102 | MP0000689_abnormal_spleen_morphology | 0.87208470 |
| 103 | MP0000716_abnormal_immune_system | 0.85946198 |
| 104 | MP0003868_abnormal_feces_composition | 0.84341620 |
| 105 | MP0009642_abnormal_blood_homeostasis | 0.83263326 |
| 106 | MP0005375_adipose_tissue_phenotype | 0.81549761 |
| 107 | MP0002398_abnormal_bone_marrow | 0.81073923 |
| 108 | MP0003279_aneurysm | 0.79606419 |
| 109 | MP0001756_abnormal_urination | 0.79208882 |
| 110 | MP0006036_abnormal_mitochondrial_physio | 0.78250507 |
| 111 | MP0005535_abnormal_body_temperature | 0.78020456 |
| 112 | MP0005390_skeleton_phenotype | 0.77362457 |
| 113 | MP0009765_abnormal_xenobiotic_induced | 0.77034457 |
| 114 | * MP0003795_abnormal_bone_structure | 0.75822073 |
| 115 | MP0002722_abnormal_immune_system | 0.75183148 |
| 116 | MP0000858_altered_metastatic_potential | 0.75006981 |
| 117 | MP0002429_abnormal_blood_cell | 0.74692720 |
| 118 | MP0000343_altered_response_to | 0.74473164 |
| 119 | MP0005166_decreased_susceptibility_to | 0.74455898 |
| 120 | MP0003075_altered_response_to | 0.74050938 |
| 121 | MP0010307_abnormal_tumor_latency | 0.73032711 |
| 122 | MP0003091_abnormal_cell_migration | 0.72982541 |
| 123 | MP0000465_gastrointestinal_hemorrhage | 0.72873934 |
| 124 | MP0001542_abnormal_bone_strength | 0.72610179 |
| 125 | MP0001663_abnormal_digestive_system | 0.71708422 |
| 126 | MP0003690_abnormal_glial_cell | 0.70114240 |
| 127 | MP0004782_abnormal_surfactant_physiolog | 0.70018150 |
| 128 | MP0005647_abnormal_sex_gland | 0.68483978 |
| 129 | MP0005023_abnormal_wound_healing | 0.67459919 |
| 130 | MP0002837_dystrophic_cardiac_calcinosis | 0.67061466 |
| 131 | MP0001661_extended_life_span | 0.66865511 |
| 132 | MP0005275_abnormal_skin_tensile | 0.66810669 |
| 133 | MP0002970_abnormal_white_adipose | 0.66514516 |
| 134 | MP0003448_altered_tumor_morphology | 0.65816213 |
| 135 | MP0000249_abnormal_blood_vessel | 0.65395630 |
| 136 | MP0003632_abnormal_nervous_system | 0.65074896 |
| 137 | MP0001851_eye_inflammation | 0.61990939 |
| 138 | MP0001849_ear_inflammation | 0.59111198 |
| 139 | MP0003879_abnormal_hair_cell | 0.58910967 |
| 140 | MP0008874_decreased_physiological_sensi | 0.57967765 |
| 141 | MP0002933_joint_inflammation | 0.57472761 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 9.43488216 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 9.43488216 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 9.43488216 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 6.20255633 |
| 5 | Dysostosis multiplex (HP:0000943) | 5.18062823 |
| 6 | Deep venous thrombosis (HP:0002625) | 5.17336489 |
| 7 | Disinhibition (HP:0000734) | 5.11430788 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.02127050 |
| 9 | Xanthomatosis (HP:0000991) | 5.01430609 |
| 10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.98897852 |
| 11 | Complement deficiency (HP:0004431) | 4.85699388 |
| 12 | Loss of speech (HP:0002371) | 4.75248536 |
| 13 | Intrahepatic cholestasis (HP:0001406) | 4.68705248 |
| 14 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.65545035 |
| 15 | Prolonged partial thromboplastin time (HP:0003645) | 4.42307827 |
| 16 | Hypobetalipoproteinemia (HP:0003563) | 4.33655178 |
| 17 | Hyperlipoproteinemia (HP:0010980) | 4.26240635 |
| 18 | Neurofibrillary tangles (HP:0002185) | 4.14452627 |
| 19 | Mutism (HP:0002300) | 4.05482072 |
| 20 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.03656938 |
| 21 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.03656938 |
| 22 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.03656938 |
| 23 | Joint hemorrhage (HP:0005261) | 3.99053348 |
| 24 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.98242459 |
| 25 | Mucopolysacchariduria (HP:0008155) | 3.87374047 |
| 26 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.87374047 |
| 27 | Hyperglycinuria (HP:0003108) | 3.83359151 |
| 28 | Abnormality of complement system (HP:0005339) | 3.81229554 |
| 29 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.72766859 |
| 30 | Hyperammonemia (HP:0001987) | 3.71176916 |
| 31 | Systemic lupus erythematosus (HP:0002725) | 3.64917297 |
| 32 | Hypolipoproteinemia (HP:0010981) | 3.54773345 |
| 33 | Abnormality of glycine metabolism (HP:0010895) | 3.45415459 |
| 34 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.45415459 |
| 35 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.45068767 |
| 36 | Abnormality of the common coagulation pathway (HP:0010990) | 3.44203101 |
| 37 | Myocardial infarction (HP:0001658) | 3.42527732 |
| 38 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.41772717 |
| 39 | Epidermoid cyst (HP:0200040) | 3.39858840 |
| 40 | Hypoalphalipoproteinemia (HP:0003233) | 3.34135143 |
| 41 | Hyperglycinemia (HP:0002154) | 3.27540951 |
| 42 | Mediastinal lymphadenopathy (HP:0100721) | 3.25253972 |
| 43 | Nuclear cataract (HP:0100018) | 3.24673698 |
| 44 | Agnosia (HP:0010524) | 3.19781661 |
| 45 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.17555036 |
| 46 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.15151413 |
| 47 | Hypoglycemic coma (HP:0001325) | 3.14427013 |
| 48 | Upper motor neuron abnormality (HP:0002127) | 3.13356633 |
| 49 | Ketosis (HP:0001946) | 3.12787590 |
| 50 | Apathy (HP:0000741) | 3.12264979 |
| 51 | Diminished motivation (HP:0000745) | 3.07454836 |
| 52 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.06805457 |
| 53 | Hypercholesterolemia (HP:0003124) | 3.00011197 |
| 54 | Cerebral inclusion bodies (HP:0100314) | 2.96617199 |
| 55 | Fat malabsorption (HP:0002630) | 2.94498594 |
| 56 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.93025615 |
| 57 | Inappropriate behavior (HP:0000719) | 2.90733906 |
| 58 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.85828960 |
| 59 | Neuronal loss in central nervous system (HP:0002529) | 2.83655684 |
| 60 | Eczematoid dermatitis (HP:0000976) | 2.81952516 |
| 61 | Nausea (HP:0002018) | 2.80444201 |
| 62 | Hyperbilirubinemia (HP:0002904) | 2.77633893 |
| 63 | Hepatocellular carcinoma (HP:0001402) | 2.75655402 |
| 64 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.74606900 |
| 65 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.74297085 |
| 66 | Hepatosplenomegaly (HP:0001433) | 2.71872853 |
| 67 | Abnormality of methionine metabolism (HP:0010901) | 2.67997309 |
| 68 | Retinal atrophy (HP:0001105) | 2.67640963 |
| 69 | Pustule (HP:0200039) | 2.66224627 |
| 70 | Hypertriglyceridemia (HP:0002155) | 2.65472601 |
| 71 | Progressive neurologic deterioration (HP:0002344) | 2.62687482 |
| 72 | Abnormality of nucleobase metabolism (HP:0010932) | 2.59182582 |
| 73 | Recurrent bacterial skin infections (HP:0005406) | 2.59151220 |
| 74 | Abnormality of the intrinsic pathway (HP:0010989) | 2.58069298 |
| 75 | Gingival bleeding (HP:0000225) | 2.55828071 |
| 76 | Obstructive lung disease (HP:0006536) | 2.55537783 |
| 77 | Chronic obstructive pulmonary disease (HP:0006510) | 2.55537783 |
| 78 | Hemorrhage of the eye (HP:0011885) | 2.54045617 |
| 79 | Glomerulonephritis (HP:0000099) | 2.53835379 |
| 80 | Personality changes (HP:0000751) | 2.52515199 |
| 81 | Abnormality of purine metabolism (HP:0004352) | 2.51625331 |
| 82 | Recurrent abscess formation (HP:0002722) | 2.47933093 |
| 83 | Acanthocytosis (HP:0001927) | 2.47767448 |
| 84 | Abnormality of proline metabolism (HP:0010907) | 2.43931711 |
| 85 | Hydroxyprolinuria (HP:0003080) | 2.43931711 |
| 86 | Dementia (HP:0000726) | 2.42535862 |
| 87 | Poikilocytosis (HP:0004447) | 2.38858816 |
| 88 | Orchitis (HP:0100796) | 2.37038863 |
| 89 | Hypochromic microcytic anemia (HP:0004840) | 2.36690737 |
| 90 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.36050941 |
| 91 | Dicarboxylic aciduria (HP:0003215) | 2.36050941 |
| 92 | Hematochezia (HP:0002573) | 2.35651826 |
| 93 | Abnormality of the periventricular white matter (HP:0002518) | 2.34744156 |
| 94 | Pancreatitis (HP:0001733) | 2.32827682 |
| 95 | Myositis (HP:0100614) | 2.30905589 |
| 96 | Steatorrhea (HP:0002570) | 2.29497033 |
| 97 | Abnormality of iron homeostasis (HP:0011031) | 2.29086004 |
| 98 | Pathologic fracture (HP:0002756) | 2.28176126 |
| 99 | Asymmetric septal hypertrophy (HP:0001670) | 2.28078138 |
| 100 | Conjugated hyperbilirubinemia (HP:0002908) | 2.25727170 |
| 101 | Peripheral demyelination (HP:0011096) | 2.24005472 |
| 102 | Cholelithiasis (HP:0001081) | 2.23606068 |
| 103 | Retrobulbar optic neuritis (HP:0100654) | 2.22455763 |
| 104 | Optic neuritis (HP:0100653) | 2.22455763 |
| 105 | Stomatitis (HP:0010280) | 2.21653032 |
| 106 | Prolonged neonatal jaundice (HP:0006579) | 2.21269625 |
| 107 | Metabolic acidosis (HP:0001942) | 2.20869340 |
| 108 | Ketoacidosis (HP:0001993) | 2.20001221 |
| 109 | Abnormality of serum amino acid levels (HP:0003112) | 2.19426903 |
| 110 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.18872511 |
| 111 | Global brain atrophy (HP:0002283) | 2.18578723 |
| 112 | Mitral stenosis (HP:0001718) | 2.17659103 |
| 113 | Abnormal gallbladder morphology (HP:0012437) | 2.17583729 |
| 114 | Increased serum ferritin (HP:0003281) | 2.16717798 |
| 115 | Gingivitis (HP:0000230) | 2.16706579 |
| 116 | Amyloidosis (HP:0011034) | 2.16464939 |
| 117 | Skin nodule (HP:0200036) | 2.15620787 |
| 118 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.14630052 |
| 119 | Esophageal varix (HP:0002040) | 2.13320550 |
| 120 | Vascular calcification (HP:0004934) | 2.12712315 |
| 121 | Pulmonary infiltrates (HP:0002113) | 2.12588939 |
| 122 | Nephritis (HP:0000123) | 2.12220162 |
| 123 | Generalized aminoaciduria (HP:0002909) | 2.11783705 |
| 124 | Petechiae (HP:0000967) | 2.11373614 |
| 125 | Vacuolated lymphocytes (HP:0001922) | 2.11102349 |
| 126 | Spontaneous hematomas (HP:0007420) | 2.10210078 |
| 127 | Bone pain (HP:0002653) | 2.08678174 |
| 128 | Cardiomegaly (HP:0001640) | 2.08308648 |
| 129 | Basal ganglia calcification (HP:0002135) | 2.06967362 |
| 130 | Thoracic kyphosis (HP:0002942) | 2.06462255 |
| 131 | Spastic diplegia (HP:0001264) | 2.04963008 |
| 132 | Recurrent skin infections (HP:0001581) | 2.03998224 |
| 133 | Joint swelling (HP:0001386) | 2.02557887 |
| 134 | Menorrhagia (HP:0000132) | 2.02004467 |
| 135 | Thrombophlebitis (HP:0004418) | 2.01993848 |
| 136 | Supranuclear gaze palsy (HP:0000605) | 2.00787177 |
| 137 | Increased CSF protein (HP:0002922) | 1.98936542 |
| 138 | Lethargy (HP:0001254) | 1.97836606 |
| 139 | Spontaneous abortion (HP:0005268) | 1.97519218 |
| 140 | Urticaria (HP:0001025) | 1.96577142 |
| 141 | Conjunctival telangiectasia (HP:0000524) | 1.95931439 |
| 142 | Cardiovascular calcification (HP:0011915) | 1.95072457 |
| 143 | Polyneuropathy (HP:0001271) | 1.94864479 |
| 144 | Gastrointestinal infarctions (HP:0005244) | 1.94466624 |
| 145 | * Purpura (HP:0000979) | 1.93259529 |
| 146 | Polycythemia (HP:0001901) | 1.93068967 |
| 147 | Epistaxis (HP:0000421) | 1.92520735 |
| 148 | Axonal loss (HP:0003447) | 1.92122500 |
| 149 | Interstitial pulmonary disease (HP:0006530) | 1.91755838 |
| 150 | Sensorimotor neuropathy (HP:0007141) | 1.89308989 |
| 151 | Reticulocytosis (HP:0001923) | 1.88140419 |
| 152 | Abnormality of macrophages (HP:0004311) | 1.87675027 |
| 153 | Pulmonary embolism (HP:0002204) | 1.86842070 |
| 154 | Recurrent fungal infections (HP:0002841) | 1.86560587 |
| 155 | Vertebral compression fractures (HP:0002953) | 1.86278817 |
| 156 | Nonimmune hydrops fetalis (HP:0001790) | 1.85959011 |
| 157 | Increased mean platelet volume (HP:0011877) | 1.85840150 |
| 158 | Abnormal platelet volume (HP:0011876) | 1.85297386 |
| 159 | Vomiting (HP:0002013) | 1.84003761 |
| 160 | Malnutrition (HP:0004395) | 1.83891027 |
| 161 | Irritability (HP:0000737) | 1.82871107 |
| 162 | Periodontitis (HP:0000704) | 1.81916953 |
| 163 | Poor head control (HP:0002421) | 1.75944810 |
| 164 | Hemoptysis (HP:0002105) | 1.75604258 |
| 165 | Protuberant abdomen (HP:0001538) | 1.75435938 |
| 166 | J-shaped sella turcica (HP:0002680) | 1.74136726 |
| 167 | Memory impairment (HP:0002354) | 1.73630286 |
| 168 | Meningitis (HP:0001287) | 1.70544194 |
| 169 | Progressive visual loss (HP:0000529) | 1.70060249 |
| 170 | Recurrent viral infections (HP:0004429) | 1.67759926 |
| 171 | Beaking of vertebral bodies (HP:0004568) | 1.64128969 |
| 172 | Premature loss of primary teeth (HP:0006323) | 1.63448399 |
| 173 | * Metaphyseal irregularity (HP:0003025) | 1.60945351 |
| 174 | Vasculitis (HP:0002633) | 1.60776741 |
| 175 | Urinary incontinence (HP:0000020) | 1.60741863 |
| 176 | Acrocyanosis (HP:0001063) | 1.59284252 |
| 177 | Prostate neoplasm (HP:0100787) | 1.58463458 |
| 178 | Abnormality of the lumbar spine (HP:0100712) | 1.57862016 |
| 179 | Mucosal telangiectasiae (HP:0100579) | 1.57819865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.01621215 |
| 2 | ERN1 | 3.74596567 |
| 3 | BCKDK | 3.52508262 |
| 4 | FGFR4 | 3.26804836 |
| 5 | GRK7 | 2.97045837 |
| 6 | SIK1 | 2.77015557 |
| 7 | TRIB3 | 2.75413634 |
| 8 | TYK2 | 2.75114218 |
| 9 | ACVR1B | 2.61921073 |
| 10 | MST1R | 2.52743840 |
| 11 | DDR2 | 2.48289718 |
| 12 | TBK1 | 2.41855080 |
| 13 | BLK | 2.41818710 |
| 14 | MAP3K14 | 2.34804870 |
| 15 | TXK | 2.32689906 |
| 16 | MATK | 2.11539355 |
| 17 | TAOK2 | 2.09678661 |
| 18 | IRAK3 | 2.00461909 |
| 19 | GRK6 | 1.98861221 |
| 20 | IKBKE | 1.97895843 |
| 21 | JAK3 | 1.96858074 |
| 22 | ZAP70 | 1.91794554 |
| 23 | JAK1 | 1.90949698 |
| 24 | PRPF4B | 1.85320566 |
| 25 | CSK | 1.85035680 |
| 26 | STK10 | 1.82766091 |
| 27 | CAMKK2 | 1.79991877 |
| 28 | TAOK1 | 1.62509216 |
| 29 | PKN2 | 1.56596535 |
| 30 | CAMK1D | 1.51695957 |
| 31 | TGFBR2 | 1.49947510 |
| 32 | MAP3K10 | 1.48628468 |
| 33 | PIM2 | 1.45697464 |
| 34 | NME2 | 1.45136511 |
| 35 | CDC42BPA | 1.41525543 |
| 36 | JAK2 | 1.37466888 |
| 37 | TAOK3 | 1.37459315 |
| 38 | TESK2 | 1.34798364 |
| 39 | MOS | 1.34434041 |
| 40 | NEK9 | 1.32589101 |
| 41 | MAPK11 | 1.28233578 |
| 42 | ITK | 1.27658197 |
| 43 | IKBKB | 1.26009502 |
| 44 | KDR | 1.25436205 |
| 45 | LRRK2 | 1.22269505 |
| 46 | FGFR3 | 1.21339039 |
| 47 | SYK | 1.20366410 |
| 48 | ADRBK2 | 1.19536689 |
| 49 | IRAK4 | 1.19051422 |
| 50 | MAP3K13 | 1.13809773 |
| 51 | TESK1 | 1.08575454 |
| 52 | MAP3K1 | 1.07782131 |
| 53 | CSF1R | 1.06417146 |
| 54 | FLT3 | 1.05210355 |
| 55 | FES | 1.03666554 |
| 56 | ABL2 | 1.02244927 |
| 57 | EIF2AK1 | 1.02140667 |
| 58 | MST4 | 0.97268684 |
| 59 | PBK | 0.95812364 |
| 60 | KIT | 0.95587205 |
| 61 | MAP2K3 | 0.92017427 |
| 62 | LCK | 0.91805316 |
| 63 | BTK | 0.88724728 |
| 64 | LYN | 0.87952638 |
| 65 | RIPK1 | 0.86319838 |
| 66 | PAK4 | 0.85676528 |
| 67 | BMPR2 | 0.84727035 |
| 68 | PIM1 | 0.84453669 |
| 69 | CDK6 | 0.84045034 |
| 70 | CDK4 | 0.83761943 |
| 71 | PTK6 | 0.83230921 |
| 72 | RIPK4 | 0.82711244 |
| 73 | HCK | 0.82434090 |
| 74 | EPHB1 | 0.79561996 |
| 75 | NLK | 0.75984732 |
| 76 | MAP2K6 | 0.75619294 |
| 77 | PRKAA2 | 0.75337304 |
| 78 | ARAF | 0.75115238 |
| 79 | RPS6KA4 | 0.75098737 |
| 80 | BMX | 0.74305594 |
| 81 | CHUK | 0.73972724 |
| 82 | MAP3K5 | 0.73403154 |
| 83 | MAP3K3 | 0.72744785 |
| 84 | MARK3 | 0.70036976 |
| 85 | TEC | 0.68921158 |
| 86 | IRAK2 | 0.68748048 |
| 87 | RPS6KA2 | 0.66058690 |
| 88 | PRKCQ | 0.64782289 |
| 89 | MAP3K11 | 0.63372309 |
| 90 | LIMK1 | 0.62990929 |
| 91 | RPS6KL1 | 0.62935534 |
| 92 | RPS6KC1 | 0.62935534 |
| 93 | ERBB4 | 0.61778018 |
| 94 | CAMK1G | 0.60400790 |
| 95 | STK4 | 0.60006862 |
| 96 | TGFBR1 | 0.59246671 |
| 97 | PIK3CG | 0.57050644 |
| 98 | PDK1 | 0.56328320 |
| 99 | DAPK2 | 0.54668643 |
| 100 | CAMKK1 | 0.54234894 |
| 101 | SIK3 | 0.53804762 |
| 102 | EPHA3 | 0.53277371 |
| 103 | PRKCH | 0.53015736 |
| 104 | MAPK4 | 0.50692103 |
| 105 | PDPK1 | 0.50050312 |
| 106 | RPS6KA6 | 0.49210252 |
| 107 | TYRO3 | 0.48940038 |
| 108 | FRK | 0.48923243 |
| 109 | MET | 0.46327971 |
| 110 | MAPK12 | 0.44554052 |
| 111 | PDGFRA | 0.43925510 |
| 112 | IGF1R | 0.43083486 |
| 113 | ABL1 | 0.42777778 |
| 114 | PRKCD | 0.42619316 |
| 115 | EPHB2 | 0.42239652 |
| 116 | TTN | 0.41846348 |
| 117 | PDK2 | 0.41457383 |
| 118 | MAP3K8 | 0.40481551 |
| 119 | MAP3K7 | 0.37191245 |
| 120 | EGFR | 0.37110918 |
| 121 | TNK2 | 0.36744823 |
| 122 | PRKACG | 0.36693663 |
| 123 | INSR | 0.34890687 |
| 124 | STK3 | 0.34726460 |
| 125 | MAP2K1 | 0.34518957 |
| 126 | GSK3A | 0.34312435 |
| 127 | MAP2K2 | 0.33491716 |
| 128 | INSRR | 0.31496738 |
| 129 | FYN | 0.31398728 |
| 130 | ICK | 0.30596331 |
| 131 | PRKG2 | 0.30173350 |
| 132 | PDK3 | 0.29231120 |
| 133 | PDK4 | 0.29231120 |
| 134 | KSR2 | 0.27547547 |
| 135 | CDK9 | 0.27313581 |
| 136 | PRKAA1 | 0.27230303 |
| 137 | FGR | 0.26598122 |
| 138 | MAPKAPK2 | 0.25209316 |
| 139 | DAPK3 | 0.24993069 |
| 140 | MAPK7 | 0.24936980 |
| 141 | IRAK1 | 0.24740772 |
| 142 | MARK2 | 0.23537084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 4.70250532 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.84219229 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.05370873 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.98836622 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.79249180 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.75747867 |
| 7 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.75485672 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.69027153 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.62781910 |
| 10 | Asthma_Homo sapiens_hsa05310 | 2.62704434 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.53020329 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50891058 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.43702402 |
| 14 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.41196912 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.39671155 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37687643 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.32312297 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.19239190 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.17341249 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.12793175 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.10147780 |
| 22 | Phagosome_Homo sapiens_hsa04145 | 2.09875893 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.06404453 |
| 24 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.97055967 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.96714478 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.91739750 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.77617774 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.77187466 |
| 29 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.77064537 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.73578216 |
| 31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.64967449 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.63665107 |
| 33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.63610744 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.60622009 |
| 35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.54869826 |
| 36 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.54843160 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52479395 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.52439112 |
| 39 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.50490310 |
| 40 | Salmonella infection_Homo sapiens_hsa05132 | 1.43696341 |
| 41 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.42791718 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.42109180 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42106177 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.41088112 |
| 45 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.40058867 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.37818088 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.32522532 |
| 48 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.32104531 |
| 49 | Viral myocarditis_Homo sapiens_hsa05416 | 1.32098911 |
| 50 | Retinol metabolism_Homo sapiens_hsa00830 | 1.30620242 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.28593195 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.28161459 |
| 53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.22240996 |
| 54 | ABC transporters_Homo sapiens_hsa02010 | 1.21417387 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 1.18721034 |
| 56 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.13846504 |
| 57 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.10674798 |
| 58 | Bile secretion_Homo sapiens_hsa04976 | 1.10634918 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.09221464 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.07973698 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.07393581 |
| 62 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.07305962 |
| 63 | Sulfur relay system_Homo sapiens_hsa04122 | 1.03247829 |
| 64 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.03075697 |
| 65 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.02917767 |
| 66 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.01447634 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.01102094 |
| 68 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.01060199 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.99371547 |
| 70 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.98174092 |
| 71 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.97823548 |
| 72 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91771076 |
| 73 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.90955270 |
| 74 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.89838482 |
| 75 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.86796837 |
| 76 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.86231493 |
| 77 | Mineral absorption_Homo sapiens_hsa04978 | 0.86040760 |
| 78 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.85149370 |
| 79 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.84098942 |
| 80 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.83708961 |
| 81 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.82348301 |
| 82 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.80153920 |
| 83 | Apoptosis_Homo sapiens_hsa04210 | 0.79294391 |
| 84 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.78010806 |
| 85 | Shigellosis_Homo sapiens_hsa05131 | 0.75195707 |
| 86 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.75051067 |
| 87 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70650616 |
| 88 | Leishmaniasis_Homo sapiens_hsa05140 | 0.70230559 |
| 89 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70049890 |
| 90 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.69761560 |
| 91 | Bladder cancer_Homo sapiens_hsa05219 | 0.69702557 |
| 92 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.69394293 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68314940 |
| 94 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.64747861 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | 0.63871721 |
| 96 | Lysine degradation_Homo sapiens_hsa00310 | 0.63826765 |
| 97 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62778736 |
| 98 | Legionellosis_Homo sapiens_hsa05134 | 0.59884066 |
| 99 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.58644800 |
| 100 | Malaria_Homo sapiens_hsa05144 | 0.58022834 |
| 101 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.57729643 |
| 102 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.57272725 |
| 103 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57265510 |
| 104 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.57241127 |
| 105 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.56292238 |
| 106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55830842 |
| 107 | Hepatitis B_Homo sapiens_hsa05161 | 0.55789968 |
| 108 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.54455656 |
| 109 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.51494518 |
| 110 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.50751751 |
| 111 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.50678189 |
| 112 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50634526 |
| 113 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.48761748 |
| 114 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.48580372 |
| 115 | Insulin resistance_Homo sapiens_hsa04931 | 0.47909283 |
| 116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47284230 |
| 117 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.47036753 |
| 118 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.46951955 |
| 119 | Measles_Homo sapiens_hsa05162 | 0.44220992 |
| 120 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.43138145 |
| 121 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43107022 |
| 122 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.42504841 |
| 123 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.42350064 |
| 124 | Pertussis_Homo sapiens_hsa05133 | 0.42325028 |
| 125 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 0.39749885 |
| 126 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.39322706 |
| 127 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37701598 |
| 128 | * Lysosome_Homo sapiens_hsa04142 | 0.36033634 |
| 129 | Endocytosis_Homo sapiens_hsa04144 | 0.35997215 |
| 130 | Prion diseases_Homo sapiens_hsa05020 | 0.34052996 |
| 131 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.33008156 |
| 132 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32886933 |
| 133 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.32720876 |
| 134 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.32663214 |
| 135 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32381118 |
| 136 | Allograft rejection_Homo sapiens_hsa05330 | 0.32120478 |
| 137 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.31864637 |
| 138 | Metabolic pathways_Homo sapiens_hsa01100 | 0.30997919 |
| 139 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30902510 |
| 140 | Tuberculosis_Homo sapiens_hsa05152 | 0.30046194 |
| 141 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.28480446 |
| 142 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27487356 |
| 143 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.26564415 |
| 144 | Hepatitis C_Homo sapiens_hsa05160 | 0.25622046 |
| 145 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.24182460 |
| 146 | Platelet activation_Homo sapiens_hsa04611 | 0.24091784 |
| 147 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.24031445 |
| 148 | Influenza A_Homo sapiens_hsa05164 | 0.23524853 |
| 149 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.23143460 |
| 150 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22891723 |
| 151 | HTLV-I infection_Homo sapiens_hsa05166 | 0.21918018 |
| 152 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.21515334 |
| 153 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.20043664 |
| 154 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.15974402 |
| 155 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.14791525 |
| 156 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.14415968 |
| 157 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.13627895 |
| 158 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.13124514 |
| 159 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.11926864 |
| 160 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.11287670 |
| 161 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.09458890 |

